SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001213900-22-006080
Filing Date
2022-02-09
Accepted
2022-02-09 12:17:21
Documents
1
Group Members
LAV BIOSCIENCES FUND V SUB A, L.P.LAV GRANITE LTDYI SHI

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ea155136-13glav_lavbiosci.htm SC 13G 106177
  Complete submission text file 0001213900-22-006080.txt   107913
Mailing Address C/O ESTERA TRUST (CAYMAN) LIMITED 75 FORT STREET, PO BOX 1350 GRAND CAYMAN E9 KY1-1108
Business Address C/O ESTERA TRUST (CAYMAN) LIMITED 75 FORT STREET, PO BOX 1350 GRAND CAYMAN E9 KY1-1108 345-640-0540
LAV Biosciences Fund V, L.P. (Filed by) CIK: 0001764435 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address BUILDING 3, 418 GUILIN ROAD XUHUI DISTRICT SHANGHAI F4 200030
Business Address BUILDING 3, 418 GUILIN ROAD XUHUI DISTRICT SHANGHAI F4 200030 00862164031522
Gracell Biotechnologies Inc. (Subject) CIK: 0001826492 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91967 | Film No.: 22605319
SIC: 2834 Pharmaceutical Preparations